High glucose suppresses expression of equilibrative nucleoside transporter 1 (ENT1) in rat cardiac fibroblasts through a mechanism dependent on PKC-ζ and MAP kinases

Journal of Cellular Physiology

Volumn 215, Issue 1, 2008, Pages 151-160

  Grden, Marzena ^a   Podgorska, Marzena ^a   Kocbuch, Katarzyna ^a   Rzepko, Robert ^a   Szutowicz, Andrzej ^a   Pawelczyk, Tadeusz ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 1; GLUCOSE; ISOENZYME; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; N(G) METHYLARGININE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; NITROBENZYLTHIOINOSINE; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN; PROTEIN KINASE C; RAPAMYCIN; WORTMANNIN; CARRIER PROTEIN; ENT1 PROTEIN, RAT; MITOGEN ACTIVATED PROTEIN KINASE KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; NITRIC OXIDE DONOR; PROTEIN KINASE C ZETA; PROTEIN KINASE INHIBITOR; RAF PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARDIAC FIBROBLAST; CELL MEMBRANE PERMEABILITY; CELL TRANSPORT; CELL TYPE; DIABETES MELLITUS; ENDOTHELIUM CELL; FIBROBLAST; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SINGLE NUCLEOTIDE POLYMORPHISM; ANIMAL; BIOLOGICAL MODEL; CELL CULTURE; CYTOLOGY; DOSE RESPONSE; DRUG EFFECT; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; HEART MUSCLE; METABOLISM; PHOSPHORYLATION; TIME; WISTAR RAT;

RATTUS;

ANIMALS; CARRIER PROTEINS; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBROBLASTS; GENE EXPRESSION REGULATION; GLUCOSE; MALE; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MITOGEN-ACTIVATED PROTEIN KINASES; MODELS, BIOLOGICAL; MYOCARDIUM; NITRIC OXIDE; NITRIC OXIDE DONORS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTEIN KINASE C; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-RAF; RATS; RATS, WISTAR; RNA, MESSENGER; TIME FACTORS;

EID: 39149089697     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21296     Document Type: Article

References (66)

1. Alessi DR, Cuenda A, Cohen P, Dudley DT, Saltiel AR. 1995. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J Biol Chem 270:27489-27494.
2. Asbun J, Villarreal FJ. 2006. The pathogenesis of myocardial fibrosis in the setting of diabetic cardiomyopathy. J Am Coll Cardiol 47:693-700.
3. Awasthi V, King RJ. 2000. PKC, p42/p44 MAPK, and p38 MAPK are required for HGF-induced proliferation of H411 cells. Am J Physiol Lung Cell Mol Physiol 279:L942-L949.
4. Bartnik M, Malberg K, Ryden L. 2003. Managing heart disease. Diabetes and the heart: Compromised myocardial function - A common challenge. Eur Heart J Suppl 5:B33-B41.
5. Berra E, Diaz-Meco MT, Lozano J, Frutos S, Municio MM, Sanchez P, Sanz L, Moscat J. 1995. Evidence for a role of MEK and MAPK during signal transduction by protein kinase C zeta. EMBO J 14:6157-6163.
6. Berti L, Mosthaf L, Kroder G, Kellerer M, Tippmer S, Mushack J, Seffer E, Seedorf K, Haring H. 1994. Glucose-induced translocation of protein kinase C isoforms in Rat-1 fibroblasts is paralleled by inhibition of the insulin receptor tyrosine kinase. J Biol Chem 269:3381-3386.
7. Booz GW, Baker KM. 1995. Molecular signaling mechanisms controlling growth and function of cardiac fibroblasts. Cardiovasc Res 30:537-543.
8. Bourbon NA, Yun J, Kester M. 2000. Ceramide directly activates protein kinase C zeta to regulate a stress-activated protein kinase signaling complex. J Biol Chem 275:35617-35623.
9. Braun MU, Mochly-Rosen D. 2003. Opposing effects of δ- and ζ-protein kinase C isozymes on cardiac fibroblasts proliferation: Use of isozyme-selective inhibitors. J Mol Cell Cardiol 35:895-903.
10. Buteau J, Foisy S, Rhodes CJ, Carpenter L, Biden TJ, Prentki M. 2001. Protein kinase C{zeta} activation mediates glucagon-like peptide-1-induced pancreatic β-cell proliferation. Diabetes 50:2237-2243.
11. Camelliti P, Borg TK, Kohl P. 2005. Structural and functional characterization of cardiac fibroblasts. Cardiovasc Res 65:40-51.
12. Chaudary N, Naydenova Z, Shuralyova I, Coe IR. 2004. Hypoxia regulates the adenosine transporter, mENT1, in murine cardiomiocyte cell line, HL-1. Cardiovasc Res 61:78-788.
13. Chuang L-Y, Guh J-Y, Wang K-A, Huang Y-J, Huang J-S. 2006. Role of nitric oxide in high glucose-induced mitogenic response in renal fibroblasts. Mol Endocrinol 20:2548-2558.
14. Coe I, Zhang Y, McKenzie T, Naydenova Z. 2002. PKC regulation of the human equilibrative nucleoside transporter hE NT1. FEBS Lett 517:201-205.
15. Corbit KC, Foster DA, Rosner MR. 1999. Protein kinase Cδ mediates neurogenic but not mitogenic activation of mitogen-activated protein kinase in neuronal cells. Mol Cell Biol 19:4209-4218.
16. Davies SP, Reddy H, Caivano M, Cohen P. 2000. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 351:95-105.
17. Dubey RK, Delberg G, Gillespie BS, Zaichuan M, Jackson EK. 1997. Exogenous and endogenous adenosine inhibits fetal calf serum-induced growth of rat cardiac fibroblasts. Circulation 96:2656-2666.
18. el-Khatib M, Radin NS, Shayman JA. 1996. Glycosphingolipid synthesis and proliferation in a renal cell line grown in high glucose. Am J Physiol Renal Physiol 270:F476-F484.
19. Farias M, San Martin R, Puebla C, Pearson JD, Casado JF, Pastor-Anglada M, Casanello P, Sobrevia L. 2006. Nitric oxide reduces adenosine transporter ENT1 gene (SLC29A1) promoter activity in human fetal endothelium from gestational diabetes. J Cell Physiol 208:451-460.
20. Fox TE, Han X, Kelly S, Merrill AH, Jr., Martin RE, Anderson RE, Gardner TW, Kester M. 2006. Diabetes alters sphingolipid metabolism in the retina: A potential mechanism of cell death in diabetic retinopathy. Diabetes 55:3573-3580.
21. Fox TE, Houck KL, O'Neill SM, Nagarajan M, Stover TC, Pomianowski PT, Unal O, Yun JK, Naides SJ, Kester M. 2007. Ceramide recruits and activates protein kinase Cζ (PKCζ) within structured membrane microdomains. J Biol Chem 282:12450-12457.
22. Fujita H, Omori S, Ishikura K, Hida M, Awazu M. 2004. ERK and p38 mediate high-glucose-induced hypertrophy and TGF-β expression in renal tubular cells. Am J Physiol Renal Physiol 286:F120-F126.
23. Gorska M, Dobrzyn A, Zendzian-Piotrowska M, Gorski J. 2004. Effect of streptozotocin-diabetes on the functioning of the sphingomyelin-signalling pathway in skeletal muscles of the rat. Hormon Metab Res 36:14-21.
24. Gschwendt M, Dieterich S, Rennecke J, Kittstein W, Mueller HJ, Johannes FJ. 1996. Inhibition of protein kinase C μ by various inhibitors. Differentiation from protein kinase c isoenzymes. FEBS Lett 392:77-80.
25. Hayat SA, Patel B, Khattar RS, Malik RZ. 2004. Diabetic cardiomyopathy: Mechanisms, diagnosis and treatment. Clin Sci 107:530-557.
26. Hirai T, Chida K. 2003. Protein kinase C zeta (PKC zeta): Activation mechanisms and cellular functions. J Biochem (Tokyo) 133:1-7.
27. House C, Kemp BE. 1987. Protein kinase C contains a pseudosubstrate prototype in its regulatory domain. Science 238:1726-1728.
28. Igarashi M, Wakasaki H, Takahara N, Ishii H, Jiang Z-Y, Yamauchi T, Kuboki K, Meier M, Rhodes CJ, King GL. 1999. Glucose or diabetes activates p38 mitogen-activated protein kinase via different pathways. J Clin Invest 103:185-195.
29. Keynan S, Khamaisi M, Dahan R, Barnes K, Jackson CD, Turner AJ, Raz I. 2004. Increased expression of endothelin-converting enzyme-1c isoform in response to high glucose levels in endothelial cells. J Vasc Res 41:131-140.
30. Lackey K, Cory M, Davis R, Frye SV, Harris PA, Hunter RN, Jung DK, McDonald OB, McNutt RW, Peel MR, Rutkowske RD, Veal JM, Wood ER. 2000. The discovery of potent cRaf1 kinase inhibitors. Bioorg Med Chem Lett 10:223-226.
31. +/nucleoside cotransporter 1 (hCNT1) and role of adenosine on hCNT1 function. J Biol Chem 279:8999-9007.
32. Leung GPH, Man RYK, Tse C-M. 2005. D-glucose upregulates adenosine transport in cultured human aortic smooth muscle cells. Am J Physiol Heart Circ Physiol 288:H2756-He2762.
33. Limatola C, Schaap D, Moolenar WH, van Blitterswijk WJ. 1994. Phosphatidic acid activation of protein kinase C-zeta overexpressed in COS cells: Comparison with other protein kinase C isotypes and other acidic lipids. Biochem J 304:1001-1008.
34. Lin S, Sahai A, Chugh SS, Pan X, Wallners EI, Danesh FR, Lomasney JW, Kanwart YS. 2002. High glucose stimulates synthesis of fibronectin via a novel protein kinase C, Rap1b, and B-Raf signaling pathway. J Biol Chem 277:41725-41735.
35. Manabe I, Shindo T, Nagai R. 2002. Gene expression in fibroblast and fibrosis involvement in cardiac hypertrophy. Circ Res 91:1103-1113.
36. Martiny-Baron G, Kazanietz MG, Mischak H, Blumberg PM, Kochs G, Hug H, Marme D, Schachtele C. 1993. Selective inhibition of protein kinase C isozymes by the indolocarbazole Go 6976. J Biol Chem 268:9194-9197.
37. Mauro A, Ciccarelli C, De Cesaris P, Scoglio A, Bouche M, Molinaro M, Aquino A, Zani BM. 2002. PKCα-mediated ERK, JNK and p38 activation regulates the myogenic program in human rhabdomyosarcoma cells. J Cell Sci 115:3587-3599.
38. Mingzhang G, Wu MH, Korompai F, Yuan SY. 2003. Upregulation of PKC genes and isozymes in cardiovascular tissues during early stages of experimental diabetes. Physiol Genomics 12:139-146.
39. Montecinos VP, Aguayo C, Flores C, Wyatt AW, Pearson JD, Mann GE, Sobrevia L. 2000. Regulation of adenosine transport by D-glucose in human fetal endothelial cells: Involvement of nitric oxide, protein kinase C and mitogen-activated protein kinase. J Physiol 529:777-790.
40. Morigi M, Angioletti S, Imberti B, Donadelli R, Micheletti G, Figliuzzi M, Remuzzi A, Zoja C, Remuzzi G. 1998. Leukocyte-endothelial interaction is augmented by high glucose concentrations and hyperglycemia in a NF-kB-dependent fashion. J Clin Invest 101:1905-1915.
41. Mubagwa K, Flaming W. 2001. Adenosine, adenosine receptors and myocardial protection: An updated overview. Cardiovasc Res 52:25-39.
42. Nakanishi H, Brewer KA, Exton JH. 1993. Activation of the zeta isozyme of protein kinase C by phosphatidylinositol 3, 4,5-trisphosphate. J Biol Chem 268:13-16.
43. Okuda Y, Kawashima K, Suzuki S, Asakura Y, Asano M, Tsurumaru K, Dai HQ, Tachi Y, Bannai C, Saitoh M, Yamashita K. 1997. Restoration of nitric oxide production by aldose reductase inhibitor in human endothelial cells cultured in high-glucose medium. Life Sci 60:PL53-PL56.
44. Parodi J, Flores C, Aguayo C, Rudolph MI, Casanello P, Sobrevia L. 2002. Inhibition of nitrobenzylthioinosine-sensitive adenosine transport by elevated D-glucose Involves activation of P2y2 purinoceptors in human umbilical vei endothelial cells. Circ Res 90:570-577.
45. Pawelczyk T, Sakowicz M, Szczepanska-Konkel M, Angielski S. 2000. Decreased expression of adenosine kinase in streptozotocin-induced diabetes mellitus rats. Arch Biochem Biophys 375:1-6.
46. Pawelczyk T, Podgorska M, Sakowicz M. 2003. The effect of insulin on expression level of nucleoside transporters in diabetic rats. Mol Pharmacol 63:81-88.
47. Pawelczyk T, Sakowicz-Burkiewicz M, Kocbuch K, Szutowicz A. 2005. Differential effect of insulin and elevated glucose ievel on adenosine handling in rat T lymphocytes. J Cell Biochem 96:1296-1310.
48. Peterman EE, Taormina P II, Harvey M, Young LH. 2004. Gö 6983 exerts cardioprotective effects in myocardial ischemia/reperfusion. J Cardiovasc Pharmacol 43:645-656.
49. Phillipson A, Petermann EE, Toarmina P, Jr., Harvey M, Brue RJ, Atkinson N, Omiyi D, Chukwu U, Young LH. 2005. Protein kinase C-z inhibition exerts cardioprotective effects in ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 289:H898-H907.
50. Podgorska M, Kocbuch K, Pawelczyk T. 2005. Recent advances on biochemical and structural properties of equilibrated and concentrative nucleoside transporters. Acta Biochim Pol 52:749-758.
51. Podgorska M, Kocbuch K, Grden M, Szutowicz A, Pawelczyk T. 2006. Reduced ability to, release adenosine by diabetic rat cardiac fibroblasts due to altered expression of nucleoside transporters. J Physiol 576:179-189.
52. Podgorska M, Kocbuch K, Grden M, Szulc A, Szutowicz A, Pawelczyk T. 2007. Different signaling pathways utilized by insulin to regulate the expression of ENT2, CNT1, CNT2 nucleoside transporters in rat cardiac fibroblasts. Arch Biochem Biophys 464:344-349.
53. Powell LA, Warpeha KM, Xu W, Walker B, Trimble ER. 2004. High glucose decreases intracellular glutathione concentrations and upregulates inducible nitric oxide synthase gene expression in intestinal epithelial cells. J Mol Endocrinol 33:797-803.
54. Prabhakar SS. 2001. Tetrahydrobiopterin reverses the inhibition of nitric oxide by high glucose in cultured murine mesangial cells. Am J Physiol Renal Physiol 281:F179-F188.
55. Quagliaro L, Piconi L, Assaloni R, Da Ros R, Maier A, Zuodar G, Ceriello A. 2005. Intermittent high glucose enhances ICAM-1, VCAM-1 and E-selectin expression in human umbilical vein endothelial cells in culture: The distinct role of protein kinase C and mitochondrial superoxide production. Atherosclerosis 183:259-267.
56. Sakowicz M, Szutowicz A, Pawelczyk T. 2004. Insulin and glucose induced changes in expression level of nucleoside transporters and adenosine transport in rat T lymphocytes. Biochem Pharmacol 68:1309-1320.
57. Sakowicz M, Szutowicz A, Pawelczyk T. 2005. Differential effect of insulin and elevated glucose level on adenosine transport in rat B lymphocytes. Int Immunol 17:145-154.
58. Summers SA, Nelson DH. 2005. A role for sphingolipids in producing the common features of type 2 diabetes, metabolic syndrome X, and Cushing's syndrome. Diabetes 54:591-602.
59. Swynghedauw B. 1999. Molecular mechanisms of myocardial remodeling. Physiol Rev 79:215-262.
60. Trachtman H, Futterweit S, Crimmins DL. 1997. High glucose inhibits nitric oxide production in cultured rat mesangial cells. J Am Soc Nephrol 8:1276-1282.
61. van der Hoeven PC, van der Wal JC, Ruurs P, van Dijk MC, van Blitterswijk J. 2000. 14-3-3 isotypes facilitate coupling of protein kinase C-zeta to Raf-1: Negative regulation by 14-3-3 phosphorylation. Biochem J 345:297-306.
62. van Dijk MCM, Muriana FJG, van der Hoeven PCJ, de Widt J, Schaap D, Moolenaar WH, van Blitterswijk WJ. 1997. Diacylglicerol generated by exogenous phospholipase C activates the mitogen-activated protein kinase pathway independent of Ras- and phorbol ester-sensitive protein kinase C: Dependence on protein kinase C-zeta. Biochem J 323:693-699.
63. Way K, Katai N, King GL. 2001. Protein kinase C and the development of diabetic vascular complications. Diabet Med 18:945-959.
64. Whiteside C, Dlugosz JA. 2002. Mesangial cell protein kinase C isozyme activation in the diabetic milieu. Am J Physiol Renal Physiol 282:F975-F980.
65. Won Y-K, Ong C-N, Shen H-M. 2005. Parthenolide sensitizes ultraviolet (UV)-B-induced apoptosis via protein kinase C-dependent pathways. Carcinogenesis 26:2149-2156.
66. Xin X, Khan ZA, Chen S, Chakrabarti S. 2004. Extracellular signal-regulated kinase (ERK) in glucose-induced and endothelin-mediated fibronectin synthesis. Lab Invest 84:1451-1459.